Endometrial cancer—how many patients could benefit from sentinel lymph node dissection?

Table 1 Risk groups according to ESMO-ESGO-ESTRO Consensus Conference [3]

	Grading	Histological type	Stage	LVSI
Low risk	G1, G2	Endometrioid	IA	Negative
Intermediate risk	G1, G2	Endometrioid	IA	Positive
	G1, G2	Endometrioid	IB	Negative
	G3	Endometrioid	IA	Negative
High-intermediate risk	G3	Endometrioid	IA	Positive
High-intermediate risk	G1, G2	Endometrioid	IB	Positive
High risk	G3	Endometrioid	IB	Negative/positive
	G3	Non-endometrioid	IA/B	Negative/positive
			II	Negative/positive

Stages IA myometrial invasion < 50%, IB myometrial invasion ≥ 50%; stage II cervical involvement; LVSI lymphovascular space invasion

ISSN: 1477-7819